Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.46 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL297615 | 1.00 | FAAH (0.47) | FAAHGPR84CA1FFAR1ABCB1 | |
| SCHEMBL6151242 | 1.00 | FAAH (0.47) | FAAHGPR84CA1FFAR1ABCB1 | |
| SCHEMBL28551183 | 0.98 | FAAH (0.46) | FAAHGPR84CA1FFAR1ABCB1 | |
| Ammonia Solution, Strong SCHEMBL28670478 | 0.98 | FAAH (0.46) | FAAHGPR84CA1FFAR1ABCB1 | |
| SCHEMBL4529720 | 0.94 | CA1 (0.46) | FAAHGPR84CA1FFAR1ABCB1 | |
| SCHEMBL28423561 | 0.93 | FAAH (0.45) | FAAHGPR84CA1FFAR1ABCB1 | |
| SCHEMBL17961068 | 0.92 | NAAA (0.44) | FAAHGPR84CA1FFAR1ABCB1 | |
| SCHEMBL29682914 | 0.91 | CA1 (0.46) | FAAHGPR84CA1FFAR1ABCB1 | |
| SCHEMBL669156 | 0.91 | CA1 (0.46) | FAAHGPR84CA1FFAR1ABCB1 | |
| SCHEMBL13870383 | 0.89 | MAPT (0.47) | FAAHGPR84CA1FFAR1ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7417162-B2 | Oily ingredient for cosmetic preparation and cosmetic preparation | KYOWA YUKA CO., LTD. (JP) | 2008-08-26 | — | — | US | claimed |
| EP-0793481-B1 | COSMETIC COMPOSITION CONTAINING HYDROXY ALKANOATE DERIVATIVES | UNILEVER PLC (GB) | 2004-06-02 | — | — | EP | claimed |
| JP-3020278-B2 | — | — | 2000-03-15 | — | — | JP | claimed |
| EP-0713385-B1 | CLEANSING COMPOSITIONS CONTAINING AN ALKANOATE AS CONDITIONER | UNILEVER PLC (GB) | 1999-03-24 | — | — | EP | claimed |
| EP-0793481-A1 | COSMETIC COMPOSITION CONTAINING HYDROXY ALKANOATE DERIVATIVES | UNILEVER PLC (GB) | 1997-09-10 | — | — | EP | claimed |
| WO-1995005153-A1 | COSMETIC COMPOSITION CONTAINING HYDROXY ALKANOATE DERIVATIVES | UNILEVER PLC (GB) | 1995-02-23 | — | — | WO | claimed |
| JP-3121152-A | — | — | None | — | — | JP | disclosed |
| WO-2026104886-A1 | METHOD FOR EXTRACTING LOW-MOLECULAR WEIGHT COLLAGEN USING POLLACK SKIN, LOW-MOLECULAR WEIGHT COLLAGEN, AND COSMETIC COMPOSITION COMPRISING SAME WITH SKIN REGENERATION EFFICACY | 유엔케이코리아 주식회사 | 2026-05-21 | — | — | WO | disclosed |
| CN-122005622-A | Composition for improving, preventing or treating vaginitis or vulvitis comprising lactobacillus salivarius HHuMin-U | 比菲德股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12414977-B2 | Method of administering seaberry and saw palmetto extracts to inhibit 5α-reductase activity | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2025-09-16 | — | — | US | disclosed |
| US-20250268972-A1 | 5a-REDUCTASE INHIBITOR | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2025-08-28 | — | — | US | disclosed |
| US-12357553-B2 | Composition for treating hair loss or promoting hair growth, comprising piperonylic acid | Hesed Bio Co., Ltd. (KR) | 2025-07-15 | — | — | US | disclosed |
| WO-2025110244-A1 | NOVEL COMPOUND AND USE THEREOF | オリザ油化株式会社 | 2025-05-30 | — | — | WO | disclosed |
| WO-2003086384-A1 | STABILIZED ASCORBIC ACID DERIVATIVES | SHOWA DENKO K. K. (JP) | 2003-10-23 | — | — | WO | disclosed |
| US-6497889-B2 | CONTAINING HYDROXYPROLINE COMPOUND | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-12-24 | — | — | US | disclosed |
| US-20020009472-A1 | Cosmetics | KYOWA HAKKO BIO CO., LTD. (JP) | 2002-01-24 | — | — | US | disclosed |
| EP-1166767-A2 | Skin care product containing hydroxyproline or N-acylated hydroxyproline derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-01-02 | — | — | EP | disclosed |
| CN-1328813-A | Cosmetics | KYOWA HAKKO KOGY CO LTD (JP) | 2002-01-02 | — | — | CN | disclosed |
| CN-1106659-A | Preparation for epidermis and process for its preparation | SANSHO SEIYAKU KK (JP) | 1995-08-16 | — | — | CN | disclosed |
| JP-H03121152-A | LIQUID COMPOSITION | LION CORP | 1991-05-23 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12357553-B2 | Composition for treating hair loss or promoting hair growth, comprising piperonylic acid | EGFR, PDGFA, HGF | FAAH 626/4885GPR84 1989/4885CA1 2793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.